DEC 09, 2017 5:55 AM PST

Severity of Mono Linked to Cross-Reactive T Cell Activity

WRITTEN BY: Kara Marker

The Epstein-Barr virus (EBV) infects almost everyone by the time they’re 30, but not everyone necessarily shows symptoms of the illness, acute infectious mononucleosis, which many call the “kissing disease.” In a new study from the American Society for Microbiology, researchers uncover details about why some people develop the illness and others don’t.

Epstein-Barr virus.

The fatigue, fever, and sore throat that are characteristic of mono are also usually accompanied by enlarged lymph nodes, swollen spleen, and a swollen liver. Some people even develop a rash. EBV can hide undetected for years of the tonsils, so the person carrying the disease is completely unaware. Someone they exchange saliva with could then unknowingly be infected with the virus and develop the illness, hence the infection’s nickname. Although the connection is not very well understood, having mono is also associated with autoimmune disease, i.e. having infectious mono may raise the risk of developing multiple sclerosis.

In the present study, researchers aimed to understand the rationale behind the development of acute infectious mono. Most children and some adults rarely develop symptoms, while others are bedridden for weeks to months. Why? Researchers believe it’s because of cross-reactive memory T cells, potentially with a connection to the flu.

Researchers conducted their study with blood samples collected from college students; 32 were diagnosed with mono, 17 tested positive for EBV but did not develop the infection. Of those with a mono diagnosis, the most severe cases showed a whopping 25 times more T cells that reacted to both EBV and influenza A virus in the blood, compared to controls. People with mild cases of mono had 10 times as many cross-reactive T cells as healthy controls.

"If you have a lot of these flu memory T-cells in your tonsils and you get EBV, instead of silently hanging around, it activates those memory cells," explained study leader Liisa Selin.

The new study suggests that a previous flu infection paired with interaction with the EBV virus could trigger an infection or make the infection more severe, making a person’s history of disease exposure a predictive factor of their risk of developing mono. Flu vaccination could also potentially provide protection from mono, at least a severe form of the illness.

The findings from this study indicate an area of research that needs to be explored further, the identification of memory T cells with receptors that increase the risk of certain diseases and increase the likelihood that those diseases will be particularly severe.

The present study was published in the journal mBio.

Sources: American Society for Microbiology, Centers for Disease Control and Prevention

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 05, 2021
Immunology
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
AUG 05, 2021
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
Talking, singing, coughing—all of these can spread COVID-19 from an infected person via respiratory aerosols. Thes ...
SEP 07, 2021
Immunology
Designer Cells for Treating Arthritis Are Activated by Inflammation
SEP 07, 2021
Designer Cells for Treating Arthritis Are Activated by Inflammation
Scientists have developed a new cell therapy for arthritis that becomes activated in the presence of inflammation. When ...
SEP 14, 2021
Immunology
The Spleen Creates Long-Lasting Protection Against the Flu Virus
SEP 14, 2021
The Spleen Creates Long-Lasting Protection Against the Flu Virus
You share an elevator with an individual who is coughing and sneezing, only to find yourself feeling unwell a few days l ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
Loading Comments...